In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people ...
A Pittsburgh-area man is not just giving people living with ALS a voice, he's giving them their own voice. A recent diagnosis ...
The ALS Network, in partnership with ALS United, today announced that Letters of Intent (LOIs) for ALS research funding will be accepted from March 16 through April 20, 2026, as part of the ...
In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people living with amyotrophic ...
Chris was diagnosed with ALS in 2024. Before that, he spent 40 years in the oil and gas industry, working and living in eight countries across five continents. He’s dedicated himself to helping others ...
Columnist Juliet Taylor reflects on the legacy of Leah Stavenhagen, who founded Her ALS Story for young women diagnosed with the disease.
Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. Actor Eric Dane’s recent death from amyotrophic lateral ...
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on developing disease-modifying treatments for neurodegenerative diseases, today ...
A Pittsburgh-area man is not just giving people living with ALS a voice, he's giving them their own voice. Meghan Schiller reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results